Quality of life of patients with paucibacillary leprosy

Iza Maria Corrêa Bottene1, Vitor Manoel Silva dos Reis

  • 1Dermatology Program, Faculdade de Medicina, Universidade de Sao Paulo, Brazil. izabottene@hotmail.com

Abstract

Insights

Early diagnosis and treatment of paucibacillary leprosy significantly reduce its impact on patients' quality of life. Most patients experienced no major quality of life impairment, indicating effective early intervention for this infectious disease.

Area of Science:

  • Dermatology
  • Public Health
  • Infectious Diseases

Background:

  • Leprosy, caused by Mycobacterium leprae, is an infectious disease affecting skin and nerves, potentially causing deformities and impacting quality of life.
  • Classified as paucibacillary (≤5 lesions) or multibacillary (>5 lesions), leprosy requires timely management to mitigate long-term effects.

Purpose of the Study:

  • To evaluate the quality of life in patients diagnosed with and treated early for paucibacillary leprosy in an outpatient setting.

Main Methods:

  • The study involved 49 outpatients receiving treatment at the Leprosy Multidisciplinary Group of the Hospital das Clínicas, University of São Paulo.
  • Quality of life was assessed using the Dermatology Life Quality Index (DLQI) and the Short Form-36 (SF-36) questionnaires.

Main Results:

  • The DLQI indicated that 63% of patients did not experience significant impairment in their quality of life.
  • The SF-36 scores suggested a slight impairment in quality of life among the study participants.

Conclusions:

  • Patients with early-diagnosed and treated paucibacillary leprosy showed no significant negative impact on their quality of life.
  • Early diagnosis and prompt treatment are crucial in minimizing the long-term influence of leprosy on patients' quality of life.